Unknown

Dataset Information

0

Inhibition of cathepsin K promotes osseointegration of titanium implants in ovariectomised rats.


ABSTRACT: The bone mineral deficiency in osteoporosis poses a threat to the long-term outcomes of endosseous implants. The inhibitors of cathepsin K (CatK) significantly affect bone turnover, bone mineral density (BMD) and bone strength in the patients with osteoporosis. Therefore, we hypothesised that the application of a CatK inhibitor (CatKI) could increase the osseointegration of endosseous implants under osteoporotic conditions. Odanacatib (ODN), a highly selective CatKI, was chosen as the experimental drug. Sixteen rats were randomised into 4 groups: sham, ovariectomy (OVX) with vehicle, OVX with low-dose ODN (5?mg/kg) and OVX with high-dose ODN (30?mg/kg). Titanium implants were placed into the distal metaphysis of bilateral femurs of each OVX rat. After 8 weeks of gavaging, CatKI treatment increased the removal torque, BMD and bone-to-implant contact (BIC). Moreover, high-dose CatKI exerted a better influence than low-dose CatKI. Furthermore, CatKI treatment not only robustly suppressed CatK gene (CTSK) expression, but also moderately reduced expression of the osteoblast-related genes Runx2, Collagen-1, BSP, Osterix, OPN, SPP1 and ALP. Thus, CatKI could affect the osteoblast-related genes, although the balance of bone turnover was achieved mainly by CatK inhibition. In conclusion, CatKI prevented bone loss and aided endosseous implantation in osteoporotic conditions.

SUBMITTER: Yi C 

PROVIDER: S-EPMC5356343 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibition of cathepsin K promotes osseointegration of titanium implants in ovariectomised rats.

Yi Chun C   Hao Ke-Yi KY   Ma Ting T   Lin Ye Y   Ge Xi-Yuan XY   Zhang Yu Y  

Scientific reports 20170317


The bone mineral deficiency in osteoporosis poses a threat to the long-term outcomes of endosseous implants. The inhibitors of cathepsin K (CatK) significantly affect bone turnover, bone mineral density (BMD) and bone strength in the patients with osteoporosis. Therefore, we hypothesised that the application of a CatK inhibitor (CatKI) could increase the osseointegration of endosseous implants under osteoporotic conditions. Odanacatib (ODN), a highly selective CatKI, was chosen as the experiment  ...[more]

Similar Datasets

| S-EPMC6901521 | biostudies-literature
| S-EPMC5903495 | biostudies-literature
| S-EPMC8066819 | biostudies-literature
| S-EPMC7822628 | biostudies-literature
| S-EPMC6690615 | biostudies-literature
2021-08-03 | GSE175428 | GEO
| S-EPMC8320438 | biostudies-literature
| S-EPMC8327665 | biostudies-literature
| S-EPMC4869100 | biostudies-other
| S-EPMC4322353 | biostudies-other